Shots:

• Organon to acquire Alydia Health for up to $240M including $215M up front out of which $50 will be paid prior to the spinoff of Organon- $165 will be paid on the closure of the acquisition while remaining will be paid upon achievement of the milestones. Alydia will also receive ~$25M as a contingent milestone
• The acquisition is expected to close after the completion of the spinoff of Organon from Merck- expected in Q2’21
• The acquisition will foster the delivery of the Jada System to prevent maternal morbidity and mortality caused by PPH or abnormal postpartum uterine bleeding

  Ref: Business Wire | Image: Merck